China Top Biotech Pharma Life Science Clinical Research Companies Insight

Kuick Research Recent Report Analyze Top 330 Pharma Biotech Companies In China With Clinical Trials Insight

Delhi, Sept. 04, 2023 (GLOBE NEWSWIRE) — China Pharmaceutical Companies Database & Drugs Pipeline Insight 2023 Highlights:

  • All Companies Are Domestic Chinese Companies
  • Chinese Pharmaceuticals Companies Business Overview Insight: 330 Companies
  • Comprehensive Insight On Drugs In Clinical Trials By Companies: > 1500 Drugs
  • Clinical Trials Insight By Companies, Indication, Formulation & Phase
  • Comprehensive Insight On Drugs Commercially Approved In Market: > 200 Drugs
  • Biosimilar, Branded & Generics Drugs Classification

Download Sample:

China has successfully established itself as one of the dominant player in the global life sciences industry, and local pharmaceutical companies and research institutions have played a key role in this. BeiGene, Shanghai Pharmaceuticals and CStone Pharmaceuticals are a few companies with a special focus on life sciences, which have shown immense success in the last couple of years because of their strong research vase and expertise in commercialization of products. The Chinese government too has had a major role in this. For instance, there are several life sciences park such as the Zhongguancun Life Science Park and the Tianfu Life Science Park, which are hotspots for academia-business synergy. These have enabled researchers to take their researchers to clinical development and application.

The life sciences industry of China is one of the largest in the world, and is still growing at an incredibly fast pace. It has been giving tough competition to the established markets of the US and EU, and is emerging as the fastest growing life sciences industry in Asia-Pacific. In order to spread their bases to other countries and increase their value in the global market, Chinese life sciences companies have also been setting up centers in different countries, which give them access to larger patient bases for clinical trials, and the most updates research and development facilities. The Chinese life sciences industry has been growing at a rapid rate, which is expected to continue in the years to come.

CONTACT: Neeraj Chawla Kuick research Research Head

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More